Table 1.
Variable | Controls (n = 91) | Patients (n = 80) | P value |
Gender (M/F) | 36/55 | 40/40 | .170 |
Age (years, Mean ± SD) | 59.98 ± 7.14 | 62.26 ± 9.51 | .096 |
TNM stage | |||
I | 25 | ||
II | 17 | ||
III | 21 | ||
IV | 17 | ||
CA19-9 (U/ml) | <.001∗ | ||
≤27 | 89 | 13 | |
>27 | 2 | 67 | |
CEA (ng/ml) | <.001∗ | ||
≤5.2 | 89 | 54 | |
>5.2 | 2 | 26 | |
CA125 (U/ml) | <.001∗ | ||
≤35 | 90 | 58 | |
>35 | 1 | 22 | |
TBIL (umol/L) | <.001 | ||
≤17.1 | 79 | 47 | |
>17.1 | 12 | 33 |